Dulaglutide, a groundbreaking glucagon-like peptide-1 (GLP-1) receptor agonist, holds a crucial role in managing type 2 diabetes. The increasing requirement for this medication has spurred the development of US-based https://inesugov020276.digitollblog.com/37351173/us-based-dulaglutide-manufacturing-advancing-diabetes-treatment